Head-to-head · Value Score
CoreAge Rx vs Alinwell
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Alinwell a 61. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameAlinwell
#369 · Grade C · Watch List
Est. first month
$249/mo month-to-month (charged every 30 days; $149 is the first month only)
Save ~82% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 61 — an est. $99/mo first month, with no teaser step-up baked in. Alinwell isn't out of it: Shoppers comparing month-two prices rather than signup prices, who want a low-dose or oral option in the same place and will read the checkout before agreeing to anything.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Alinwell |
|---|---|---|
| Value Score | 93 (A+) | 61 (C) |
| Est. first month | $99/mo | $249/mo month-to-month (charged every 30 days; $149 is the first month only) |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $99/mo | $249/mo month-to-month (charged every 30 days; $149 is the first month only) |
| Tirzepatide | $149/mo | $299/mo month-to-month (charged every 30 days; $199 is the first month only) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states claimed, no list published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Alinwell
A women's GLP-1 program advertising semaglutide "from $149/mo" that its own checkout labels a first-month discount off $249, with a three-month plan that costs more per month than the price on the homepage.
Why it's a deal
- The full ladder is visible at the checkout before payment: $249 and $299 standing, $219 and $269 on three months, $189 and $239 on six, plus $149 for the microdose and $150 for the oral program — a complete price list, even though the marketing shows only its cheapest corner
- Four programs rather than two: full-dose semaglutide and tirzepatide, a low-dose injectable at $149 a month with no prepay tier attached, and an oral GLP-1 at $150
- Certificates of analysis are published for the compounded batches and they name the compounders — Emerald Compounding Pharmacy in Tampa and Boudreaux's New Drug Store in Lake Charles, both with street addresses and one with a phone number
- The certificates also disclose what is in the injection: both GLP-1s are compounded with glycine, a fact the product copy never mentions and the intake only asks about as an allergy
- A real address and phone number are published on the contact page, and clinical hours are stated rather than implied
The fine print
- The advertised price is an introductory price. "From $149/mo" is what the checkout calls "$100 off first month"; the standing rate is $249 for semaglutide and $299 for tirzepatide, so a reader budgeting from the homepage will be wrong by $1,200 a year
- Because the advertised figure is an intro rate, the commitment plans look like a penalty: the plan marked most popular costs $219 a month against an advertised $149, and the six-month card strikes the three-month price rather than the monthly one
- Three incompatible cancellation rules are published at once — 48 hours' notice in the terms, 30 days' notice in the treatment-page questions, and "cancel anytime, no contracts" on the checkout and the homepage banner. Which one governs is exactly what a reader needs to know
- The terms and the privacy policy print an unedited template where the company's address belongs: "123 Example Street, Suite 100, Your City, WI, 92308", while the contact page gives a real Texas address. The legal pages a buyer would rely on were never filled in
- No clinician, medical group, license number or identifier appears anywhere on the site, and neither the microdose nor the oral program says which molecule it contains
- The checkout says "You're Approved" and runs a countdown reading "Approval expires in 14:56" before any clinician has seen the file — the next screen then explains that a physician reviews the information after payment
- Patient counts and ratings disagree across the site: 10,000-plus, 1,743-plus and 7,200-plus patients on three surfaces, and five different average ratings. The review badge on the homepage points at a profile that does not exist, checked the same day against a known-good profile that did
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Alinwell.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.